Daniel E. Rothschild

664 total citations
15 papers, 532 citations indexed

About

Daniel E. Rothschild is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Daniel E. Rothschild has authored 15 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Daniel E. Rothschild's work include Inflammasome and immune disorders (5 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune Response and Inflammation (3 papers). Daniel E. Rothschild is often cited by papers focused on Inflammasome and immune disorders (5 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune Response and Inflammation (3 papers). Daniel E. Rothschild collaborates with scholars based in United States and Switzerland. Daniel E. Rothschild's co-authors include Irving C. Allen, Dylan K. McDaniel, Sheryl Coutermarsh‐Ott, Tere Williams, Bettina Heid, Christopher C. Benz, Veronica M. Ringel‐Scaia, Thomas E. Cecere, Gary K. Scott and Martin D. Brand and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Journal of Leukocyte Biology.

In The Last Decade

Daniel E. Rothschild

15 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Rothschild United States 11 368 186 84 80 47 15 532
Jae Woong Shim South Korea 17 396 1.1× 181 1.0× 78 0.9× 83 1.0× 62 1.3× 25 587
Xuezhi Yang China 14 308 0.8× 201 1.1× 90 1.1× 113 1.4× 45 1.0× 28 690
Bingfeng Song China 16 262 0.7× 364 2.0× 111 1.3× 155 1.9× 39 0.8× 22 759
Jingjing Wei China 10 172 0.5× 185 1.0× 59 0.7× 98 1.2× 25 0.5× 37 466
Hua Gu China 13 216 0.6× 103 0.6× 57 0.7× 115 1.4× 26 0.6× 32 487
JN Rashida Gnanaprakasam United States 11 288 0.8× 286 1.5× 124 1.5× 144 1.8× 22 0.5× 12 671
Fangcheng Zhang China 11 338 0.9× 83 0.4× 122 1.5× 61 0.8× 60 1.3× 17 533
Michael Scannell Ireland 6 263 0.7× 249 1.3× 60 0.7× 36 0.5× 30 0.6× 8 517
Wanying Shan China 13 285 0.8× 99 0.5× 129 1.5× 121 1.5× 33 0.7× 22 552

Countries citing papers authored by Daniel E. Rothschild

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Rothschild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Rothschild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Rothschild more than expected).

Fields of papers citing papers by Daniel E. Rothschild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Rothschild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Rothschild. The network helps show where Daniel E. Rothschild may publish in the future.

Co-authorship network of co-authors of Daniel E. Rothschild

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Rothschild. A scholar is included among the top collaborators of Daniel E. Rothschild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Rothschild. Daniel E. Rothschild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Morrison, Holly A., et al.. (2024). NF-κB Inducing Kinase Attenuates Colorectal Cancer by Regulating Noncanonical NF-κB Mediated Colonic Epithelial Cell Regeneration. Cellular and Molecular Gastroenterology and Hepatology. 18(3). 101356–101356. 4 indexed citations
2.
Rothschild, Daniel E., Dylan K. McDaniel, Veronica M. Ringel‐Scaia, & Irving C. Allen. (2018). Modulating inflammation through the negative regulation of NF-κB signaling. Journal of Leukocyte Biology. 103(6). 1131–1150. 80 indexed citations
3.
Eden, Kristin, Daniel E. Rothschild, Dylan K. McDaniel, Bettina Heid, & Irving C. Allen. (2017). Noncanonical NF-κB signaling and the essential kinase NIK modulate crucial features associated with eosinophilic esophagitis pathogenesis. Disease Models & Mechanisms. 10(12). 1517–1527. 17 indexed citations
4.
McDaniel, Dylan K., Ami Jo, Veronica M. Ringel‐Scaia, et al.. (2016). TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments. Nanomedicine Nanotechnology Biology and Medicine. 13(3). 1255–1266. 13 indexed citations
5.
Rothschild, Daniel E., et al.. (2016). The <em>Ex Vivo</em> Culture and Pattern Recognition Receptor Stimulation of Mouse Intestinal Organoids. Journal of Visualized Experiments. 4 indexed citations
6.
Rothschild, Daniel E., Yao Zhang, Na Diao, et al.. (2016). Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M. EBioMedicine. 15. 36–47. 19 indexed citations
7.
Scott, Gary K., David Chu, Ravneet Kaur, et al.. (2016). ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition. Oncotarget. 8(48). 83432–83445. 15 indexed citations
8.
Brickler, Thomas, Sheryl Coutermarsh‐Ott, Tere Williams, et al.. (2016). Nonessential Role for the NLRP1 Inflammasome Complex in a Murine Model of Traumatic Brain Injury. Mediators of Inflammation. 2016. 1–11. 56 indexed citations
9.
10.
Williams, Tere, Daniel E. Rothschild, Sheryl Coutermarsh‐Ott, et al.. (2015). The NLRP1 Inflammasome Attenuates Colitis and Colitis-Associated Tumorigenesis. The Journal of Immunology. 194(7). 3369–3380. 133 indexed citations
11.
Allen, Irving C., Tere Williams, Daniel E. Rothschild, et al.. (2015). The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis (MUC5P.750). The Journal of Immunology. 194(1_Supplement). 138.8–138.8. 1 indexed citations
12.
Rothschild, Daniel E., et al.. (2014). mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms. Breast Cancer Research and Treatment. 144(2). 287–298. 43 indexed citations
13.
Goncalves, Renata L.S., Daniel E. Rothschild, Casey L. Quinlan, et al.. (2014). Sources of superoxide/H2O2 during mitochondrial proline oxidation. Redox Biology. 2. 901–909. 63 indexed citations
14.
Scott, Gary K., Christina Yau, Daniel E. Rothschild, et al.. (2014). RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. Oncotarget. 5(13). 5165–5176. 32 indexed citations
15.
Williams, Tere, Daniel E. Rothschild, Dylan K. McDaniel, et al.. (2014). Caspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 308(2). G139–G150. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026